Dr. Shailesh Patel, MD
What this data tells you about Dr. Patel
Dr. Shailesh Patel is a hematology specialist in Pensacola, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 154,565 Medicare services across 3,120 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $3,637 from 30 pharmaceutical and/or device companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells | 27,180 | $0 | $2 |
| Iron infusion (Feraheme) | 17,340 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 16,400 | $43 | $131 |
| Anti-nausea injection (fosaprepitant) | 13,500 | $0 | $6 |
| Darbepoetin injection (Aranesp) for anemia | 13,150 | $2 | $21 |
| Azacitidine chemotherapy injection | 12,400 | $0 | $14 |
| Paclitaxel chemotherapy injection | 10,374 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 8,970 | $1 | $8 |
| Contrast dye for imaging (iodine-based) | 8,895 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 5,940 | $19 | $46 |
| Immune globulin infusion (Octagam) | 3,040 | $34 | $232 |
| Epoetin alfa injection (Retacrit) for anemia | 2,700 | $6 | $30 |
| Dexamethasone injection (steroid) | 2,322 | $0 | $1 |
| Office visit, established patient (30-39 min) | 1,730 | $95 | $224 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,710 | $1 | $122 |
| Iron infusion (Monoferric) | 1,400 | $16 | $71 |
| Injection, granisetron hydrochloride, 100 mcg | 870 | $0 | $25 |
| Injection of additional new drug or substance into vein | 702 | $12 | $105 |
| Injection, leucovorin calcium, per 50 mg | 540 | $3 | $27 |
| Administration of chemotherapy into vein, 1 hour or less | 472 | $101 | $686 |
| Injection, magnesium sulfate, per 500 mg | 422 | $1 | $6 |
| Injection, carboplatin, 50 mg | 412 | $2 | $300 |
| Injection, fluorouracil, 500 mg | 392 | $2 | $12 |
| Injection, gadobenate dimeglumine (multihance), per ml | 380 | $1 | $16 |
| Drug injection, under skin or into muscle | 370 | $11 | $93 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 306 | $22 | $152 |
| Injection, zoledronic acid, 1 mg | 226 | $7 | $462 |
| Administration of chemotherapy into vein, each additional hour | 207 | $22 | $156 |
| Injection, diphenhydramine hcl, up to 50 mg | 171 | $1 | $5 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 151 | $46 | $304 |
| Administration of additional new drug or substance into vein, 1 hour or less | 134 | $50 | $334 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 134 | $410 | $638 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 127 | $1,204 | $4,120 |
| Office visit, established patient, complex (40-54 min) | 127 | $138 | $301 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 121 | $15 | $97 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 120 | $54 | $205 |
| New patient office visit (45-59 min) | 84 | $125 | $343 |
| CT scan of abdomen and pelvis with contrast | 78 | $234 | $1,400 |
| Ct scan of chest with contrast | 72 | $89 | $1,005 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 72 | $38 | $226 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 72 | $4 | $26 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 68 | $25 | $141 |
| Blood creatinine level | 63 | $5 | $30 |
| Hospital follow-up visit, high complexity | 60 | $96 | $232 |
| Diagnostic mammography of both breasts | 54 | $113 | $536 |
| Administration of additional new drug or substance into vein using push technique | 52 | $43 | $281 |
| Office visit, established patient (20-29 min) | 41 | $63 | $148 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 40 | $1 | $19 |
| New patient office visit, complex (60-74 min) | 35 | $164 | $432 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 35 | $133 | $986 |
| Irrigation of implanted venous access drug delivery device | 32 | $18 | $111 |
| Initial hospital admission, high complexity | 32 | $128 | $412 |
| CT scan of chest, without contrast | 30 | $93 | $861 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 30 | $15 | $91 |
| Infusion into a vein for hydration, 31-60 minutes | 26 | $23 | $249 |
| Bone density scan (DEXA) | 23 | $37 | $421 |
| Screening mammography | 22 | $125 | $433 |
| Infusion, normal saline solution , 1000 cc | 22 | $2 | $19 |
| Diagnostic mammography of 1 breast | 19 | $77 | $424 |
| Collection of blood sample from implanted device | 17 | $18 | $64 |
| Mri scan of abdomen before and after contrast | 17 | $266 | $3,458 |
| Complete ultrasound scan of 1 breast | 17 | $121 | $432 |
| 3D screening mammography (tomosynthesis) | 17 | $52 | $226 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (49%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with moderate Medicare volume, with mixed engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with filgrastim injection (nivestym) for white blood cells?
Does Dr. Patel receive payments from pharmaceutical companies?
How do Dr. Patel's costs compare to other hematologists in Pensacola?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology